News & Updates
Filter by Specialty:
3D-printed masks a good alternative to N95 respirators
Reusable 3D-printed respirators offer a cost-effective alternative to N95 masks in providing protection against respiratory pathogens, such as SARS-CoV-2, suggests a recent study. In addition, fit testing results show that some 3D-printed mask designs appear to exceed the fit of N95 masks.
3D-printed masks a good alternative to N95 respirators
12 Sep 2022Patients upset by frequent side effects of RA drugs
Symptomatic adverse events (AEs) are common and troublesome for many patients with rheumatoid arthritis (RA) who are taking medications for their condition, results of an exploratory study have shown.
Patients upset by frequent side effects of RA drugs
12 Sep 2022CNS metastasis worsens survival in endometrial cancer
Among patients with endometrial cancer (EC), central nervous system metastasis (CNSm) is strongly associated with poor prognoses and survival outcomes, a recent study has found.
CNS metastasis worsens survival in endometrial cancer
12 Sep 2022Bladder-directed heated chemotherapy of no clear benefit in NMIBC
In patients with intermediate-risk nonmuscle-invasive bladder cancer (NMIBC), intravesical chemohyperthermia (CHT) does not translate to better cancer control than standard room-temperature chemotherapy, according to a recent phase II study HIVEC-II.
Bladder-directed heated chemotherapy of no clear benefit in NMIBC
12 Sep 2022Add-on pyrotinib in neoadjuvant setting safe, effective for HER2-positive advanced breast cancer
In the treatment of patients with HER2-positive locally advanced breast cancer, adding pyrotinib to trastuzumab plus chemotherapy in the neoadjuvant setting yields high response rates while being safe, according to the results of NeoATP trial.
Add-on pyrotinib in neoadjuvant setting safe, effective for HER2-positive advanced breast cancer
12 Sep 2022Antihypertensive drugs confer durable BP reduction in white-coat hypertension
Antihypertensive medications prove to be effective and lasting in decreasing office blood pressure (BP) among individuals with white-coat hypertension (WCH), suggests a study.